Results 81 to 90 of about 649 (195)

CLASSIFICAÇÃO DOS JUROS E DIVIDENDOS NA DEMONSTRAÇÃO DOS FLUXOS DE CAIXA DAS EMPRESAS BRASILEIRAS

open access: yesRevista Ambiente Contábil, 2015
O objetivo principal deste trabalho foi analisar a classificação dos juros e dividendos nas Demonstrações de Fluxo de Caixa de empresas brasileiras de capital aberto.
Lara Núbia Silvestre   +1 more
doaj  

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

BOARD OF DIRECTORS AND AUDIT COMMITTEE CHARACTERISTICS OF LISTED COMPANIES ON THE BM&FBOVESPA

open access: yes, 2018
Este estudio tuvo como objetivo verificar las características del consejo de administración y del comité de auditoría de las empresas listadas en la BM&FBovespa. Con ese propósito, se realizó una investigación descriptiva con enfoque cuantitativo y procedimiento documental de recolección de datos.
Reyes, Marilbeth Carolina Rodríguez   +3 more
openaire   +1 more source

Comparability of Accounting Choices in Investment Properties of BM&FBOVESPA and NYSE Listed Companies

open access: yesContabilidade, Gestão e Governança, 2017
This research aimed to identify the consequence of the accounting choices made by public companies managers listed on the NYSE and the BM&FBOVESPA, in relation to the subsequent measurement of investment properties, through identifying the comparability degree of financial reports from the year 2013. The degree of comparability was calculated using
Botinha, Reiner Alves, Lemes, Sirlei
openaire   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

INTANGIBILITY LEVEL FRONT OF CONVERGENCE TO IFRS IN LISTED COMPANIES IN BM & FBOVESPA

open access: yes, 2016
O objetivo desse estudo é verificar o impacto do processo de convergência às IFRS no grau de intangibilidade de empresas listadas na BM&FBOVESPA. O universo da pesquisa é composto pelas companhias brasileiras listadas na BM&FBovespa. A amostra final compreendeu 904 observações no período de 2006 a 2012.
Ramos, Fernando Maciel   +3 more
openaire   +1 more source

Micro-level transmission of monetary policy shocks: The trading book channel. [PDF]

open access: yesJ Econ Behav Organ, 2020
Silva TC   +3 more
europepmc   +1 more source

Fatores condicionantes da liquidez das ações: efeitos dos níveis de governança, ADR e crise econômica

open access: yesBBR: Brazilian Business Review, 2014
Níveis de governança da BM&FBOVESPA podem ser vistos como forma de alinhar os interesses entre agente e principal. Um dos benefícios anunciados pela adesão aos níveis é o aumento da liquidez de ações.
Ricardo Luiz Menezes da Silva   +3 more
doaj  

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy